Clinical trial
Leptin to Treat Lipodystrophy
NCT00025883 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00025883 |
|---|---|
| Title | Leptin to Treat Lipodystrophy |
| Official title | Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lipodystrophy |
| Intervention type | Drug |
| Interventions | Metreleptin |
| Enrollment | 103 |
| Start date | Oct 1, 2001 |
| Primary completion | Feb 1, 2015 |
| Completion | Feb 1, 2015 |
| First posted | Oct 29, 2001 |
| Last update posted | Aug 16, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: